Infertility
Conditions
Interventions
Oral administration of Premarin (0.632mg per tablet, twice a day)
Embrocation of Estrogen patch (2.16mg per day in Estrogen conversion)
Sponsors
Oak Clinic
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Infertile patients. Provided written informed consent.
Exclusion criteria
Exclusion criteria: The patient who corresponds to a contraindicated matter for each estrogen preparation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implantation rate and clinical pregnancy rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Ongoing pregnancy rate | — |
Countries
Japan
Contacts
Public ContactYoshitaka Nakamura
Oak Clinic IVF Center
Outcome results
None listed